Literature DB >> 17641020

Both infiltrating regulatory T cells and insufficient antigen presentation are involved in long-term cardiac xenograft survival.

Wenhao Chen1, Jun Diao, Stanislaw M Stepkowski, Li Zhang.   

Abstract

We have previously shown that pretransplant donor lymphocyte infusion (DLI) together with transient depletion of CD4(+) T cells could induce permanent rat-to-mouse heart graft survival, whereas depleting CD4(+) T cells alone failed to do so. In this study, we investigated the mechanism leading to long-term xenograft survival. We found that peripheral CD4(+) T cells from DLI/anti-CD4-treated mice could mount rat heart graft rejection after adoptive transfer into B6 CD4(-/-) mice. Infusing donor-Ag-loaded mature dendritic cells (DCs) could break long-term cardiac xenograft survival in DLI/anti-CD4-treated mice. Interestingly, when the number and phenotype of graft-infiltrating cells were compared between anti-CD4- and DLI/anti-CD4-treated groups, we observed a significant increase in both the number and suppressive activity of alphabeta-TCR(+)CD3(+)CD4(-)CD8(-) double negative regulatory T cells and decrease in the numbers of CD4(+) and CD8(+) T cells in the xenografts of DLI/anti-CD4-treated mice. Moreover, there was a significant reduction in MHC class II-high DCs within the xenografts of DLI/anti-CD4-treated recipients. DCs isolated from the xenografts of anti-CD4- but not DLI/anti-CD4-treated recipients could stimulate CD4(+) T cell proliferation. Our data indicate that functional anti-donor T cells are present in the secondary lymphoid organs of the mice that permanently accepted cardiac xenografts. Their failure to reject xenografts is associated with an increase in double negative regulatory T cells as well as a reduction in Ag stimulation by DCs found within grafts. These findings suggest that local regulatory mechanisms need to be taken into account to control anti-xenograft T cell responses.

Entities:  

Mesh:

Year:  2007        PMID: 17641020     DOI: 10.4049/jimmunol.179.3.1542

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.

Authors:  Stephen C Juvet; Li Zhang
Journal:  J Mol Cell Biol       Date:  2012-02       Impact factor: 6.216

2.  Infusion of ex-vivo expanded human TCR-αβ+ double-negative regulatory T cells delays onset of xenogeneic graft-versus-host disease.

Authors:  P Achita; D Dervovic; D Ly; J B Lee; T Haug; B Joe; N Hirano; L Zhang
Journal:  Clin Exp Immunol       Date:  2018-07-31       Impact factor: 4.330

3.  Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction.

Authors:  Jie Wu; Hedong Zhang; Xiaomin Shi; Xiang Xiao; Yihui Fan; Laurie J Minze; Jin Wang; Rafik M Ghobrial; Jiahong Xia; Roger Sciammas; Xian C Li; Wenhao Chen
Journal:  Immunity       Date:  2017-12-05       Impact factor: 31.745

4.  Critical role of OX40 in the expansion and survival of CD4 T-cell-derived double-negative T cells.

Authors:  Guangyong Sun; Xiaojing Sun; Wei Li; Kai Liu; Dan Tian; Yiran Dong; Xuelian Sun; Hufeng Xu; Dong Zhang
Journal:  Cell Death Dis       Date:  2018-05-23       Impact factor: 8.469

5.  A novel differentiation pathway from CD4⁺ T cells to CD4⁻ T cells for maintaining immune system homeostasis.

Authors:  X Zhao; G Sun; X Sun; D Tian; K Liu; T Liu; M Cong; H Xu; X Li; W Shi; Y Tian; J Yao; H Guo; D Zhang
Journal:  Cell Death Dis       Date:  2016-04-14       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.